phone icon  Int'l : +1 (503) 505-6949
0
Shopping Cart is Empty..
$ 0

World Digital Pathology Market

- Opportunities and Forecasts, 2012 - 2020
 Report Code: ME 1474
 Pages: 83
 Format: PDF Exel CD_rom
pub_n Published: Mar 2014
tab_nTables: 27
aut_nAuthor(s):

The digital pathology is a new technology that has digitalized the instruments used in the pathology labs for testing. The digitalization has led to the automation of the tests done during the diagnosis procedures. For example, a single digital instrument operated by a single pathologist can perform tests that were previously done using five instruments. The global digital pathology market, valued at $1.98 billion in 2012, is estimated to reach $5.7 billion by 2020. Automation in the conventional methods of pathology is the major driving force of this market, which has resulted in workflow efficiency, efficiency in analysis. Thus, resulting in fast and accurate results of the pathology tests. The other driving factors of this market are diagnosis that can be provided to patients in the remote regions and reduction in the cost of diagnosis. The cost includes procedure cost and the cost involved in delivery of the slides & data. The major limitation of the digital pathology market is the stringent regulations involved during the approval of digital pathology systems. The other limitation is the cost involved in the integration of DPS in the pathology labs. The challenges faced by the DP market are standardization and interoperability of the technology as the formats differ from region to region.

The digital pathology market is segmented into components, end users and geography. The products market consists of the Whole slide imaging (WSI), Image analysis- informatics and Storage, communication and integrated platforms. The WSI is the highest revenue generating market among the segments; however, image analysis-informatics market is expected to have the highest growth potential. The end users market is segmented into pharmaceutical research, clinical organizations and educational institutes. The pharmaceutical research is the highest revenue generating market and is also expected to have the highest growth potential. The geography market is dominated by the North American region, which is the highest revenue generating region; however, Asian market is expected to have the highest CAGR during the analysis period.

The key companies profiled in this report include Definiens AG, Digipath, Inc., Leica Microsystems Gmbh, Ventana medical systems, Inc., Nikon Corporation, Visiopharm, Philips healthcare, Indica Labs, Inc, Omnyx LLC and 3DHISTECH, Ltd.

digital pathology

KEY BENEFITS

  • In-depth analysis of the digital pathology market, which is segmented on the basis of products, end users and geographies are discussed in the report at a greater length
  • Quantitative analysis of the current market and estimations through 2013-2020, Thus helping digital pathology systems manufacturers to analyze the market
  • Assessment and ranking of the factors affecting the global market and their impact  on the digital pathology market
  • Study on the bargaining power of buyers and suppliers in the market, based on porter’s five force analysis. Thus helping digital pathology systems manufacturers to analyze the market
  • Analysis of trends in various geographic segments that would help the companies to plan their strategies depending on the region
  • SWOT and competitive analysis of the key players, which would help stakeholders to understand trends followed by their competitors and take actionable decisions.

KEY MARKET SEGMENTS

BY COMPONENTS

  • Whole slide imaging (WSI)
  • Image analysis- informatics
  • Storage, and communication and integrated platforms

BY END-USERS

  • Pharmaceutical research
  • Clinical organizations
  • Educational institutes

BY GEOGRAPHY

  • North America
  • Europe
  • Asia Pacific
  • RoW
Table Of Content
* Pricing on the website is provided for single users licenses only. All reports will be provided in a PDF format for download. To purchase multi-user licenses, please contact us at +1 617 674 4143 or send an email to sales@alliedmarketresearch.com
Title/ Chapter Name Price

Chapter: 1. INTRODUCTION

1.1 Key benefits
1.2 Key audiences
1.3 Research methodology

1.3.1 Secondary research
1.3.2 Primary research
1.3.3 Analyst tools and models

$0(SU) €0(SU) £0(SU)

Chapter: 2. EXCECUTIVE SUMMARY

$195(SU) €0(SU) £0(SU)

Chapter: 3. GLOBAL DIGITAL PATHOLOGY MARKET OVERVIEW

3.1 Market definition and scope
3.2 Introduction
3.3 Conventional pathology Vs digital pathology
3.4 Image analysis and data retrieval
3.5 Management systems in digital pathology
3.6 Global access to data
3.7 Clinical trials using digital pathology
3.8 Information systems in digital pathology
3.9 Key findings

3.9.1 Top ten factors impacting digital pathology market
3.9.2 Top winning strategies in the digital pathology market
3.9.3 Top investment pockets in digital pathology market

3.9.3.1 Digital pathology market by product
3.9.3.2 Digital pathology market by end users

3.9.4 Porter’s Five Forces Analysis

3.9.4.1 Competition among the suppliers reduces the power of the suppliers
3.9.4.2 Availability of wide range of products enhances the buyer’s power
3.9.4.3 Emerging market creates high competition
3.9.4.4 Cost factor lowers the threat of new entrants
3.9.4.5 High cost encourages substitution

3.10 Reimbursement scenario
3.11 Regulatory issues
3.12 Case study

3.12.1 Case study: 1 digital pathology used in critical diagnosis
3.12.2 Case study: 2 examples and initiatives of deploying telepathology in emerging economies
3.12.3 Case study: 3 Role of digital pathology in saving cost of pharma companies

3.13 Market dynamics

3.13.1 Drivers

3.13.1.1 Cost efficiency
3.13.1.2 Ease in transportation
3.13.1.3 Efficient analysis
3.13.1.4 Raise in adoption
3.13.1.5 Efficiency in workflow
3.13.1.6 System efficiency
3.13.1.7 Diagnosis in remote regions
3.13.1.8 High efficiency

3.13.2 Restraints
3.13.3 Opportunities and challenges

$995(SU) €0(SU) £0(SU)

Chapter: 4. GLOBAL DIGITAL PATHOLOGY MARKET BY PRODUCTS

4.1 Global DP market by products, 2012-2020 ($Million)
4.2 Global DP products market by geography, 2012-2020 ($Million)
4.3 Whole slide imaging (WSI)

4.3.1 Global DP Whole slide imaging market by geography, 2012-202 ($Million)

4.4 Image analysis- informatics

4.4.1 Drivers

4.4.1.1 Helps in decision making
4.4.1.2 Automation to analyze numerous images
4.4.1.3 Compare image data with other data
4.4.1.4 To study complex morphologies and features

4.4.2 Global DP image analysis- informatics market by geography, 2012-2020 ($Million)

4.5 Storage, communication and information management systems

4.5.1 Global DP information management system ,storage & communication market by geography, 2012-2020 ($Million)

$1295(SU) €0(SU) £0(SU)

Chapter: 5. GLOBAL DIGITAL PATHOLOGY MARKET BY END USERS

5.1 Global DP market by end users, 2012-2020 ($Million)
5.2 Global DP end user market by geography, 2012-2020 ($Million)
5.3 Pharmaceutical research

5.3.1 Global DP pharmaceutical research market by geography, 2012-2020 ($Million)

5.4 Clinical organizations

5.4.1 Global DP clinical organizations market by geography, 2012-2020 ($Million)

5.5 Educational institutes

5.5.1 Global DP educational institutes market by geography, 2012-202 ($Million)

$1295(SU) €0(SU) £0(SU)

Chapter: 6. GLOBAL DIGITAL PATHOLOGY MARKET BY GEOGRAPHY

6.1 North America

6.1.1 North American DP market, 2012-2020 ($Million)

6.2 Europe

6.2.1 European DP market, 2012-2020 ($Million)

6.3 Asia

6.3.1 ASIAN DP market, 2012-2020, ($million)

6.4 RoW

6.4.1 RoW DP market, 2012-2020 ($Million)

$795(SU) €0(SU) £0(SU)

Chapter: 7. COMPANY PROFILES

7.1 Philips healthcare

7.1.1 Company overview
7.1.2 Company snapshot
7.1.3 Business performance
7.1.4 Strategic moves and developments
7.1.5 SWOT Analysis of Philips healthcare

7.2 Definiens AG

7.2.1 Company overview
7.2.2 Company snapshot
7.2.3 Strategic moves and developments
7.2.4 Swot Analysis of Definiens

7.3 Digipath, Inc.

7.3.1 Company overview
7.3.2 Company snapshot
7.3.3 Strategic moves and developments
7.3.4 Swot Analysis of Digipath, Inc.

7.4 Leica Microsystems Gmbh

7.4.1 Company overview
7.4.2 Company snapshot
7.4.3 Strategic moves and developments
7.4.4 Swot Analysis of Leica Microsystems

7.5 Ventana Medical systems, Inc.

7.5.1 Company overview:
7.5.2 Company snapshot
7.5.3 Strategic moves and developments
7.5.4 SWOT Analysis of Ventana Medical Systems, Inc.

7.6 Nikon Corporation

7.6.1 Company overview
7.6.2 Company snapshot
7.6.3 Business performance
7.6.4 Strategic moves and developments
7.6.5 SWOT Analysis of Nikon Corporation

7.7 Visiopharm

7.7.1 Company overview
7.7.2 Company snapshot
7.7.3 Strategic moves and developments
7.7.4 SWOT Analysis of Visiopharm

7.8 3DHISTECH

7.8.1 Company Overview
7.8.2 Company snapshot
7.8.3 Strategic moves and Development
7.8.4 Swot Analysis of 3DHISTECH

7.9 Indica labs

7.9.1 Company overview
7.9.2 Company snapshot
7.9.3 Strategic moves and developments
7.9.4 SWOT Analysis of Indica Labs

7.10 Omnyx

7.10.1 Company overview
7.10.2 Company snapshot
7.10.3 Strategic moves and developments
7.10.4 SWOT Analysis of Omnyx, LLC.

 

LIST OF TABLES

TABLE 1    GLOBAL DP PRODUCTS MARKET BY GEOGRAPHY, 2012-2020($MILLIONS)
TABLE 2    GLOBAL DP MARKET BY PRODUCTS, 2012-2020 ($MILLION)
TABLE 3    GLOBAL DP PRODUCTS MARKET BY GEOGRAPHY, 2012-2020($MILLION)
TABLE 4    WHOLE SLIDE IMAGING SCANNERS BY VARIOUS COMPANIES
TABLE 5    GLOBAL DP WHOLE SLIDE IMAGING MARKET BY GEOGRAPHY, 2012-2020($MILLION)
TABLE 6    IMAGE ANALYSIS SOFWARE BY VARIOUS COMPANIES
TABLE 7    GLOBAL DP IMAGE ANALYSIS- INFORMATICS MARKET BY GEOGRAPHY, 2012-2020 ($MILLION)
TABLE 8    GLOBAL DP INFORMATION MANAGEMENT SYSTEM ,STORAGE & COMMUNICATION MARKET BY GEOGRAPHY, 2012-2020 ($MILLION)
TABLE 9    GLOBAL DP MARKET BY END USER, 2012-2020 ($MILLION)
TABLE 10  GLOBAL DP END USER MARKET BY GEOGRAPHY, 2012-2020($MILLION)
TABLE 11  GLOBAL DP PHARMACEUTICAL RESEARCH MARKET BY GEOGRAPHY, 2012-2020 ($MILLION)
TABLE 12  GLOBAL DP CLINICAL ORGANIZATION MARKET BY GEOGRAPHY, 2012-2020 ($MILLION)
TABLE 13  GLOBAL DP EDUCATIONAL INSTITUTES MARKET BY GEOGRAPHY, 2012-2020 ($MILLION)
TABLE 14  NORTH AMERICAN DP MARKET, 2012-2020 ($MILLION)
TABLE 15  EUROPE DP MARKET, 2012-2020 ($MILLION)
TABLE 16  ASIAN DP MARKET, 2012-2020 ($MILLION)
TABLE 17  ROW DP MARKET, 2012-2020 ($MILLION)
TABLE 18  PHILIPS HEALTHCARE BUSINESS SNAPSHOT
TABLE 19  DEFINIENS BUSINESS SNAPSHOT
TABLE 20  DIGIPATH, INC BUSINESS SNAPSHOT
TABLE 21  LEICA MICROSYSTEMS BUSINESS SNAPSHOT
TABLE 22  VENTANA MEDICAL SYSTEMS, INC.BUSINESS SNAPSHOT
TABLE 23  NIKON CORPORATION BUSINESS SNAPSHOT
TABLE 24  VISIOPHARM BUSINESS SNAPSHOT
TABLE 25  3DHISTECH BUSINESS SNAPSHOT
TABLE 26  INDICA LABS BUSINESS SNAPSHOT
TABLE 27  OMNYX, LLC. BUSINESS SNAPSHOT

 

LIST OF FIGURES

FIG. 1    DIGITAL PATHOLOGY MARKET DEFINITION
FIG. 2    TOP FACTORS IMPACTING DIGITAL PATHOLOGY MARKET (2013-2020)
FIG. 3    TOP INVESTMENT MARKET BY PRODUCT
FIG. 4    TOP INVESTMENT MARKET BY END USER
FIG. 5    PORTER’S FIVE FORCE ANALYSIS
FIG. 6    DIGITAL PATHOLOGY WORKFLOW
FIG. 7    STORAGE WORKFLOW
FIG. 8    CLOUD STORAGE SYSTEM
FIG. 9    REVENUE BY SALES IN BUSINESS UNITS, 2012
FIG. 10    SWOT ANALYSIS OF PHILIPS HEALTHCARE
FIG. 11    SWOT ANALYSIS OF DEFINIENS
FIG. 12    SWOT ANALYSIS OF DIGIPATH, INC
FIG. 13    SWOT ANALYSIS OF LEICA MICROSYSTEMS
FIG. 14    SWOT ANALYSIS OF VENTANA MEDICAL SYSTEMS, INC.
FIG. 15    REVENUE BY GEOGRAPHIC SALES , 2013
FIG. 16    REVENUE BY SALES IN BUSINESS UNITS, 2013
FIG. 17    SWOT ANALYSIS OF NIKON CORPORATION
FIG. 18    SWOT ANALYSIS OF VISIOPHARM
FIG. 19    SWOT ANALYSIS OF 3DHISTECH
FIG. 20    SWOT ANALYSIS OF INDICA LABS
FIG. 21    SWOT ANALYSIS OF OMNYX, LLC.

$595(SU) €0(SU) £0(SU)

The digital pathology market is an emerging market that is used in the pathology field and is replacing the conventional pathology methods. The key reason for the adoption of the digital pathology system is its reduction in cost, fast and easy delivery of slides. Thus, helps in efficient analysis of the slide through DPS (digital pathology system). This also includes discussion with other pathologists during analysis.

The digital pathology market analyzed in this report includes the various products and the end users. The products market is segmented into Whole slide imaging (WSI), Image analysis- informatics and storage, communication and integrated platforms. This report excludes the in-depth analysis of the application market in digital pathology.

Digital pathology management system software makes archival and retrieval of data easy and in large volumes; thus, helping pathologists to analyze large volumes of data in project specific configurations. Data retrieval tools make it easy for the pathologists to access and search information on multiple criteria. The criteria are by specimen, digital image, case and subcategories such as scan date, type of stain used, etc. the system automatically applies complex algorithms to an entire slide to improve the image quality. This makes interpretation more objective, quantitative and accurate. Tedious analysis is simplified by automation achieved by the image analysis algorithms, such as estimating protein expression or cell counting. An algorithm simplifies the task that requires repetitiveness such as tissue classification, assay quantification and pattern recognition.

This market research report is an effort to provide the clear picture of the state of the market and sub markets over the next seven years. The report provides micro level analysis of the factors affecting the market, key market trends and industry drives and challenges for the better understanding of the market structure. The presentation of the market dynamics, competitive scenario and developments will enable marketers to aptly design their growth strategies and have competitive edge. Moreover, assessment of the top investment pockets and winning strategies will help in channelizing their investments in the right directions to garner better proceeds.

SINGLE USER
GROUP LICENSE
SITE LICENSE
GLOBAL LICENSE
$4515
$5325
$7350
$10680
SUPPORT
Delivery Formats
20% Free customization (Pre-sale)
16 Analyst hour support (Post Sale)
40 Analyst hour support (Post Sale)
160 hours of mini-consult
Free quarterly industry update
Free report on update (within 180 days)
MULTIPLE PURCHASE
Complimentary report with 2 reports
Complimentary report with 3 reports
Subscription Model
Have questions ?
connect
Need to add more ?
request

Single User $4515
Group User $5325
Site User $7350
Global User $10680
Need More Information
phone_n +1 (503) 505-6949

Help AMR help@alliedmarketresearch.com
Or
Send Enquiry
WHY ALLIED MARKET RESEARCH?
Infallible Methodology
To ensure high level data integrity, accurate analysis and impeccable forecasts
ANALYST SUPPORT
For complete satisfaction
CUSTOMIZATION
On-demand customization of scope of the report to exactly meet your needs
TARGETED MARKET
Targeted market view to eliminate redundant information to provide valued information and save time of the reader
RECENTLY VIEWED REPORTS
get_n
SIMILAR MARKET REPORTS
  • ...
    One of the key reasons for adoption of flow cytometry technology is its precise deliverance of results comparing to conventional methods such as ELISA. The emergence of this technology as one of the leading applications has brought various advancements in the diagnosis of diseases such as HIV and cancer as well as in research fields. With rising advancements in information technology, it finds application in drug discovery and development. Moreover, it is now used in hematopoietic stem cell research, multiparameter analysis and pharmacogenesis.
    Dec 2013 | Price: $4515(SU) €0(SU) £0(SU) | View Details >>
  • ...
    Syphilis is one of the vital sexually transmitted infections (STIs) caused by the bacteria named, Treponema pallidum, and can lead to long-term complications, if not diagnosed adequately. Syphilis continues to be a global health concern due to the increasing incidences occurring mainly among bisexuals, gays and MSM (men who have sex with men).
    May 2015 | Price: $3930(SU) €0(SU) £0(SU) | View Details >>
  • ...
    Umbilical cord blood stem cells are potential stem cells that can convert into any type of -determined cells. Global stem cell market is dominating the healthcare industry with its reliable and cost effective method of treatment with fewer side effects. Current market for cord blood therapeutics accounts for $6.5 billion, which is expected to grow at 33.4% CAGR from 2013-2020. Other segments of this market include - Adult stem cell and embryonic stem cells. Government authorities are supporting the research and clinical trials of cord blood stem cell, which is currently increasing the interest of healthcare companies to invest in research and commercialization of cord blood stem cell therapies.
    Jan 2014 | Price: $4515(SU) €0(SU) £0(SU) | View Details >>
  • ...
    Biosimilars or follow-on-biologics are highly similar versions of reference biologics derived from living organisms such as plants and animals. The development of biosimilars and validation with reference biologics play a significant role in the commercialization of biosimilars. Economic pricing of biosimilars, ease in development and a quick approval process are some key driving factors that drive the growth of this market. Effective and timely formulated regulations facilitate the viability and balance between original and biosimilar products.
    Sep 2015 | Price: $4515(SU) €0(SU) £0(SU) | View Details >>
ON DEMAND REPORTS
  • ...
    Vertebral Compression Fracture (VCF) is a medical condition that occur due to the fractures, cracks and collapses in the bone of spinal column. Vertebral compression fractures are most often caused by osteoporosis, which accounts for ~85% of all VCF cases. It can also occur due to trauma, multiple myeloma, metastasis and malignant bone tumors that may cause spine collapse.
    Mar 2016 | View Details >>
  • ...
    Neurovascular disease is a condition caused to nervous tissues vascular structure, neurons and blood vessels that leads to serious brain damages such as stroke, and cerebral hemorrhage. The global market for central nervous system disease was accounted to approximately $78 billion in 2010. Neurovascular disease market is mainly driven by the increase in number of patients suffering from neurological diseases. According to University of California, San Francisco (USCF), there are approximately 600,000 people suffering from stroke, out of which 10% are recovered. Almost 30% patients die due to stroke, and 60% of the patients remain disabled.
    Mar 2016 | View Details >>
  • ...
    Acute Lymphocytic/Lymphoblastic leukemia is a kind of blood or bone marrow cancer. It occurs in lymphocytes which are white blood cells. It can then easily spread to the other parts of the body such as liver, spleen, lymph nodes and others. The number of cases of these diseases is rising at an alarming rate all over the globe.
    Mar 2016 | View Details >>
  • ...
    The Global Leukemia market involves acute and chronic conditions, namely acute myeloid leukemia, acute lymphoblastic leukemia, chronic myeloid leukemia and chronic lymphocytic leukemia. Acute lymphoblastic leukemia is a hematological malignancy, which results in an abnormal increase in blood cells, i.e., immature WBCs (lymphoblast). It affects the blood, lymphoid system and bone marrow. It is believed that genetic and environmental factors are responsible for this group of cancers. Acute leukemia is more prevalent in infants; however, it can be also diagnosed in adults. A complete analysis of the global acute lymphoblastic leukemia therapeutics market provides various aspects of market research such as market trends, market drivers, restrains and opportunities.
    Mar 2016 | View Details >>